LRCX
49
-3
SRE
69
3
CNX
80
4
NI
73
3
AFL
49
3
XRAY
17
-12
MOS
48
2
WBA
53
6
HP
44
3
PX
79
6
AVGO
37
-7
FLR
45
-3
ICE
62
3
DFS
73
3
NRG
52
-5
DE
40
4
XOM
48
-2
AEE
66
6
ADT
58
-3
LNC
50
5
LRCX
49
-3
SRE
69
3
CNX
80
4
NI
73
3
AFL
49
3
XRAY
17
-12
MOS
48
2
WBA
53
6
HP
44
3
PX
79
6
AVGO
37
-7
FLR
45
-3
ICE
62
3
DFS
73
3
NRG
52
-5
DE
40
4
XOM
48
-2
AEE
66
6
ADT
58
-3
LNC
50
5
Financhill
Back

PodcastOne 10K Form

Buy
72

PODC
PodcastOne

Last Price:
1.61
Seasonality Move:
-35.94%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PODC News And Ratings

See the #1 stock for the next 7 days that we like better than PODC

PODC Financial Statistics

Sales & Book Value

Annual Sales: $43.3M
Cash Flow: $-554K
Price / Cash Flow: 85.33
Annual Sales: $0.66
Price / Book: 2.44

Profitability

EPS (TTM): -0.74000
Net Income (TTM): $-15.89M
Gross Margin: $5.98M
Return on Equity: -109.18%
Return on Assets: -60.44%

PodcastOne Earnings Forecast

Key PodcastOne Financial Ratios

  • The Gross Profit Margin over the past 3 years for PODC is 13.80%.
  • The Selling, General & Administrative Expenses for PODC have been equal to 23.11% of Gross Profit Margin.
  • The Research & Development expenses have been 0.20% of Revenue.
  • The Interest Expense is -15.25% of Operating Income.
  • The Net Earning history of PODC is -34.02% of Total Revenues.
  • Per Share Earnings over the last 3 years have been positive in 0 years.

PodcastOne Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Entertainment
Sector: Communication Services
Current Symbol: PODC
Website: podcastone.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.11
Quick Ratio: 0.96

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PODC Technical Analysis vs Fundamental Analysis

Buy
72
PodcastOne (PODC) is a Buy

Is PodcastOne a Buy or a Sell?

  • PodcastOne stock is rated a Buy
    The current PodcastOne [PODC] share price is $1.59. The Score for PODC is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.